Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03479437 · ClinicalTrials.gov registry record

The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry

A clinical trial, sponsored by Rhythm Pharmaceuticals.

Completed
Registry status
303
Enrollment target

NCT03479437 is a clinical trial that has completed, run by Rhythm Pharmaceuticals. The registered enrollment target is 303 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03479437 has completed, sponsored by Rhythm Pharmaceuticals.

COMPLETED
Registry status
303 participants
Enrollment target

Study Summary

A voluntary prospective study that will allow registration and follow-up of individuals with MC4R pathway genetic obesity.

Trial Details

FieldValue
Enrollment Target 303 participants
Start Date 2018-04-15
Est. Completion 2020-12-01

Sponsor

Rhythm Pharmaceuticals

23 total trials

What the Registry Record Tells You About NCT03479437

The ClinicalTrials.gov registry entry for NCT03479437 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhythm Pharmaceuticals, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03479437 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03479437 about?

NCT03479437 is a clinical study titled "The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry". A voluntary prospective study that will allow registration and follow-up of individuals with MC4R pathway genetic obesity.

What is the current status of trial NCT03479437?

This trial is currently completed. The enrollment target is 303 participants. The study started on 2018-04-15. Estimated completion is 2020-12-01.

Who is sponsoring clinical trial NCT03479437?

This trial is sponsored by Rhythm Pharmaceuticals, which has 23 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.